Product Details
Formula
C23H24ClN3O5
MW
457.92
Purity
>97%
Solubility (DMSO Mg/MI)
15
Storage (Powder)
3 Years -20?C
Storage (Solvent)
1 Year -80?C
Indication
Cervical Cancer, Lung Cancer, Ovarian and Fallopian Tube or Primary Peritoneal Cancer
Mode Of Action
inhibitor
Drug Status
Approved
Target Name
DNA topoisomerase I (TOP1)
Research Area
CANCER
Research Area Sub Group
Anticancer
Pharmacology
ENZYMES
Pharmacology Area Sub Group
Isomerase